Bitcoin’s rally above $71,000 lifted MicroStrategy (Strategy Inc) stock and other crypto-linked names, with analysts maintaining Buy ratings but trimming targets as BTC weakens, underscoring Strategy as a high‑beta Bitcoin proxy rather than a traditional software stock.

Strategy shares rose roughly 6.5% on August 21, 2026, as the company advances an AI-driven product expansion and continues bitcoin treasury activity.

Crypto-linked equities, including Strategy and Coinbase, tracked Bitcoin higher as the price moved above Strategy’s cost basis, fueling further gains.

Disclaimer noted that the article does not constitute financial advice and that investments can lose value.

Sigel reported WULF’s CFO retained all 500,000 vested shares with no tax withholding, described as a sizable insider buy.

H100 Group AB announced the completion of its acquisition of NSD AS, reorganizing to give direct and indirect ownership of Moonshot AS and PDI AS.

The deal was governed by a Share Purchase Agreement dated April 23, 2026, with completion on August 10, 2026, including a 12-month lock-up for the principal seller on the consideration shares.

H100 Group, a Sweden-listed health-tech and Bitcoin treasury company, posted a second‑quarter pre‑tax loss of 98 million kronor and a half‑year loss of 253 million kronor.

Risks noted include Ether volatility, staking and custody risks, potential dilution, funding, taxation, regulatory changes, and that gross token value may not reflect net asset value.

Strategy disclosed holding 5,815,164 ETH as of August 17, about 4.8% of total supply, with roughly $11.01 billion in value at the earlier price and $13.22 billion after mark‑to‑market changes.

Share dilution from new shares was about 70%, diluting existing holders to roughly 30% of the combined equity.

Sats per basic share remained unchanged, while sats per fully diluted share rose about 5% due to dilution, maintaining bitcoin exposure while expanding the treasury.